About ABUS Dividend Returns
Arbutus Biopharma Corporation (ABUS) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of ABUS over the past year?
Arbutus Biopharma Corporation (ABUS) delivered a return of 35.07% over the past year. Since ABUS does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in ABUS be worth today?
A $10,000 investment in Arbutus Biopharma Corporation one year ago would be worth $13,507 today, representing a gain of $3,507.
Q3Does ABUS pay dividends?
Arbutus Biopharma Corporation (ABUS) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For ABUS, the total return equals the price-only return.
Q4Did ABUS beat the S&P 500?
Yes, Arbutus Biopharma Corporation (ABUS) outperformed the S&P 500 by 19.62 percentage points over the past year. ABUS delivered a total return of 35.07%, compared to the S&P 500's 15.45%. This 19.62pp alpha means investors in ABUS earned more than a passive S&P 500 index fund.
Q5What is ABUS's worst drawdown?
Arbutus Biopharma Corporation (ABUS) experienced a maximum drawdown of -25.86% over the past year, declining from its peak on 2025-12-15 to its trough on 2026-02-05. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is ABUS's long-term total return over 10, 20, or 30 years?
Arbutus Biopharma Corporation (ABUS) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is 47.5% (4.0% CAGR) — $10,000 would have grown to $14,747. Over 20 years: -26.0% total return (-1.5% CAGR) — $10,000 → $7,397. Over 30 years: -26.0% total return (-1.0% CAGR) — $10,000 → $7,397. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was ABUS's best and worst year?
Arbutus Biopharma Corporation's best calendar year was 2012 with a total return of 211.9%. Its worst year was 2008 with a total return of -71.6%. This range shows the volatility investors should expect — the difference between the best and worst year is 283.5 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).